对新的突触核蛋白病生物学研究标准的担忧。 - Suppr

Suppr

超能文献

Concerns with the new biological research criteria for synucleinopathy.

作者信息

Boeve Bradley F, Davis Albert A, Ju Yo-El, Kantarci Kejal, Singer Wolfgang, Videnovic Aleks

机构信息

Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.

Department of Neurology, Washington University, St. Louis, MO, USA.

出版信息

Lancet Neurol. 2024 Jul;23(7):659-660. doi: 10.1016/S1474-4422(24)00213-8.

DOI:10.1016/S1474-4422(24)00213-8

PMID:38876735

Abstract

摘要

相似文献

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):659-660. doi: 10.1016/S1474-4422(24)00213-8.

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):660-661. doi: 10.1016/S1474-4422(24)00225-4.

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):663. doi: 10.1016/S1474-4422(24)00215-1.

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):662. doi: 10.1016/S1474-4422(24)00214-X.

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):662-663. doi: 10.1016/S1474-4422(24)00211-4.

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):661. doi: 10.1016/S1474-4422(24)00222-9.

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):659. doi: 10.1016/S1474-4422(24)00217-5.

Concerns with the new biological research criteria for synucleinopathy - Authors' reply.

Lancet Neurol. 2024 Jul;23(7):666-668. doi: 10.1016/S1474-4422(24)00212-6.

Concerns with the new biological research criteria for synucleinopathy - Authors' reply.

Lancet Neurol. 2024 Jul;23(7):663-666. doi: 10.1016/S1474-4422(24)00233-3.

Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies.

Biomark Med. 2022 May;16(7):499-509. doi: 10.2217/bmm-2021-0646. Epub 2022 Mar 11.

引用本文的文献

Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies.

Alzheimers Dement. 2025 Jul;21(7):e70470. doi: 10.1002/alz.70470.

Implementing a tridimensional diagnostic framework for personalized medicine in neurodegenerative diseases.

Alzheimers Dement. 2025 Feb;21(2):e14591. doi: 10.1002/alz.14591.

Validating the Accuracy of Parkinson's Disease Clinical Diagnosis: A UK Brain Bank Case-Control Study.

Ann Neurol. 2025 Jun;97(6):1110-1121. doi: 10.1002/ana.27190. Epub 2025 Jan 27.

Initial biological classification of Lewy body diseases: No consensus on terminology.

Alzheimers Dement. 2025 Feb;21(2):e14449. doi: 10.1002/alz.14449. Epub 2024 Dec 28.

本文引用的文献

A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria.

Lancet Neurol. 2024 Feb;23(2):191-204. doi: 10.1016/S1474-4422(23)00404-0.

A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.

Lancet Neurol. 2024 Feb;23(2):178-190. doi: 10.1016/S1474-4422(23)00405-2.

Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder.

Neurology. 2023 May 2;100(18):e1944-e1954. doi: 10.1212/WNL.0000000000207147. Epub 2023 Mar 17.

Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.

Brain. 2021 Feb 12;144(1):278-287. doi: 10.1093/brain/awaa365.

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study.

Brain. 2019 Mar 1;142(3):744-759. doi: 10.1093/brain/awz030.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Concerns with the new biological research criteria for synucleinopathy.

作者信息

Boeve Bradley F, Davis Albert A, Ju Yo-El, Kantarci Kejal, Singer Wolfgang, Videnovic Aleks

机构信息

Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.

Department of Neurology, Washington University, St. Louis, MO, USA.

出版信息

Lancet Neurol. 2024 Jul;23(7):659-660. doi: 10.1016/S1474-4422(24)00213-8.

DOI:10.1016/S1474-4422(24)00213-8

PMID:38876735

Abstract

摘要

相似文献

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):659-660. doi: 10.1016/S1474-4422(24)00213-8.

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):660-661. doi: 10.1016/S1474-4422(24)00225-4.

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):663. doi: 10.1016/S1474-4422(24)00215-1.

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):662. doi: 10.1016/S1474-4422(24)00214-X.

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):662-663. doi: 10.1016/S1474-4422(24)00211-4.

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):661. doi: 10.1016/S1474-4422(24)00222-9.

Concerns with the new biological research criteria for synucleinopathy.

Lancet Neurol. 2024 Jul;23(7):659. doi: 10.1016/S1474-4422(24)00217-5.

Concerns with the new biological research criteria for synucleinopathy - Authors' reply.

Lancet Neurol. 2024 Jul;23(7):666-668. doi: 10.1016/S1474-4422(24)00212-6.

Concerns with the new biological research criteria for synucleinopathy - Authors' reply.

Lancet Neurol. 2024 Jul;23(7):663-666. doi: 10.1016/S1474-4422(24)00233-3.

Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies.

Biomark Med. 2022 May;16(7):499-509. doi: 10.2217/bmm-2021-0646. Epub 2022 Mar 11.

引用本文的文献

Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies.

Alzheimers Dement. 2025 Jul;21(7):e70470. doi: 10.1002/alz.70470.

Implementing a tridimensional diagnostic framework for personalized medicine in neurodegenerative diseases.

Alzheimers Dement. 2025 Feb;21(2):e14591. doi: 10.1002/alz.14591.

Validating the Accuracy of Parkinson's Disease Clinical Diagnosis: A UK Brain Bank Case-Control Study.

Ann Neurol. 2025 Jun;97(6):1110-1121. doi: 10.1002/ana.27190. Epub 2025 Jan 27.

Initial biological classification of Lewy body diseases: No consensus on terminology.

Alzheimers Dement. 2025 Feb;21(2):e14449. doi: 10.1002/alz.14449. Epub 2024 Dec 28.

本文引用的文献

A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria.

Lancet Neurol. 2024 Feb;23(2):191-204. doi: 10.1016/S1474-4422(23)00404-0.

A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.

Lancet Neurol. 2024 Feb;23(2):178-190. doi: 10.1016/S1474-4422(23)00405-2.

Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder.

Neurology. 2023 May 2;100(18):e1944-e1954. doi: 10.1212/WNL.0000000000207147. Epub 2023 Mar 17.

Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.

Brain. 2021 Feb 12;144(1):278-287. doi: 10.1093/brain/awaa365.

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study.

Brain. 2019 Mar 1;142(3):744-759. doi: 10.1093/brain/awz030.